WellDoc’s Series B just got closer to $30 million.
The Midtown-based company, which makes an app for managing type 2 diabetes, announced a total of $29.5 million in its Series B on Tuesday. In December, company officials said they raised $22 million, led by Samsung Venturesand Merck Global Health Innovation Fund.
Though the company is not disclosing how much money each investor provided, a new addition is Johnson & Johnson Innovation — the venture arm of the consumer products giant.
Read more at Technical.ly Baltimore
from http://baltimoretech.org/news/johnson-johnson-joins-welldocs-big-funding-round/
No comments:
Post a Comment